Medexus has announced that Triamcinolone Hexacetonide Injectable Suspension 20 mg/mL (Intra-Articular/Periarticular/Intrasynovial Injection) is now available in Canada.
Triamcinolone Hexacetonide (TH) Injectable Suspension is indicated for intra-articular, intrasynovial, or periarticular use in adults and adolescents for the symptomatic treatment of subacute and chronic inflammatory joint diseases including:
- Rheumatoid arthritis
- Juvenile Idiopathic Arthritis (JIA)
- Osteoarthritis and post-traumatic arthritis
- Synovitis, tendinitis, bursitis and epicondylitis
Geriatrics (over 65 years of age):
No overall differences in safety or effectiveness were observed between elderly subjects and younger subjects. Reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
Pediatrics (3-12 years of age):
Triamcinolone Hexacetonide Injectable Suspension may be used as an intra-articular injection in children aged 3-12 years with Juvenile Idiopathic Arthritis (see WARNINGS AND PRECAUTIONS – Special Populations, and DOSAGE AND ADMINISTRATION).
October 9, 2018
Triamcinolone Hexacetonide (TH) is available at all wholesalers and can be ordered by any pharmacy.
Each carton contains 10 ampoules